Alector (ALEC) Research & Development (2018 - 2026)
Alector's (ALEC) quarterly Research & Development came in at $17.9 million in Q1 2026, down 46.92% year-on-year from $33.6 million in Q1 2025, and down 44.99% on a QoQ basis from $32.5 million in Q4 2025.
Alector (ALEC) Research & Development (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Research & Development data on file, last reported at $17.9 million in Q1 2026.
- On a quarterly basis, Research & Development fell 46.92% year-over-year to $17.9 million in Q1 2026; TTM through Mar 2026 was $107.3 million, a 38.49% decrease from a year earlier, with the FY2025 full-year figure at $123.1 million, down 33.81% from the prior year.
- Research & Development for Q1 2026 stood at $17.9 million, down from $32.5 million in the prior quarter.
- Over the last five years, Research & Development for ALEC reached as high as $54.5 million in Q2 2022 and fell as low as $17.9 million in Q1 2026.
- Historically, Research & Development has averaged $42.9 million across 5 years, with a median of $46.3 million in 2023.
- Across the five-year window, Research & Development climbed 15.98% in 2022 and sank 46.92% in 2026, its largest moves.
- Year by year, Research & Development stood at $54.5 million in 2022, then decreased by 12.42% to $47.7 million in 2023, then declined by 2.64% to $46.5 million in 2024, then tumbled by 30.13% to $32.5 million in 2025, then plunged by 44.99% to $17.9 million in 2026.
- Per Business Quant data, the three most recent Research & Development figures were $17.9 million in Q1 2026, $32.5 million in Q4 2025, and $29.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 541.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -2.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.37 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 343.97 Mn |
| 10 | Alector | 164.78 Mn | -41.74 Mn | - | 17.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.86 Mn |
| Dec 31, 2025 | 32.46 Mn |
| Sep 30, 2025 | 29.35 Mn |
| Jun 30, 2025 | 27.61 Mn |
| Mar 31, 2025 | 33.64 Mn |
| Dec 31, 2024 | 46.46 Mn |
| Sep 30, 2024 | 48.00 Mn |
| Jun 30, 2024 | 46.31 Mn |
| Mar 31, 2024 | 45.17 Mn |
| Dec 31, 2023 | 47.72 Mn |
| Sep 30, 2023 | 46.33 Mn |
| Jun 30, 2023 | 46.18 Mn |
| Mar 31, 2023 | 51.89 Mn |
| Dec 31, 2022 | 54.49 Mn |
| Sep 30, 2022 | 48.35 Mn |
| Jun 30, 2022 | 54.53 Mn |
| Mar 31, 2022 | 53.04 Mn |
| Dec 31, 2021 | 52.79 Mn |
| Sep 30, 2021 | 43.07 Mn |
| Jun 30, 2021 | 47.82 Mn |